| dc.description.abstract | In regenerative medicine, human adipose tissue-derived mesenchymal stem cells (hadMSCs) have
exhibited tremendous promise in providing an efficient approach for chronic cardiovascular diseases.
Noble effects of mesenchymal stem cells (MSCs) have been acknowledged to attribute not only to
cellular engraftment and response to the site of injury but paracrine action via the release of extracellular
vesicles (EVs), notably, exosomes. This study aims to investigate more about the roles of exosomes
derived from hadMSCs (hadMSC-Exo) in the angiogenesis effect. Firstly, hadMSCs were characterized
and cultured at a density of 500,000 cells in a T75 flask for 48 hours. The conditioned medium was
ultracentrifuged for exosome isolation. Exosomes were confirmed for CD9, CD63, and CD81 markers
by flow cytometry and imaged by TEM assessment. Human umbilical vein endothelial cells (HUVECs)
culture was established for the angiogenesis model under treatment of hadMSC-Exo. The expression of
some specific angiogenesis-related genes including growth and adheren factors were identified by RTqPCR. The result of the Bradford assay shown that the concentration of total protein in isolated
exosomes was 0.51 ± 0.04 µg/ml. Exosomes were successfully isolated and characterized by their
morphology and immunophenotype. The results showed that exosomes significantly escalated the
mRNA expression of TGF by 11.56 ± 2.03, Flk-1 by 4.04 ± 0.01, VE-Cadherin by 7.25 ± 2.30, and
CD31 by 3.02 ± 1.13 (P < 0.05). The study suggested that exosomes promoted angiogenesis of
endothelial cells in vitro | en_US |
